12,311 filings from 18 companies since 1998-04-10, newest first, each with the facts the site holds from it. Last indexed: Form 144 CLSK 2026-09-04.
Index read from the SEC submissions API on 2026-09-06; XBRL facts from the companyfacts API; no extraction from prose has run, so 8-K exhibits and press releases show zero facts held. Filters and the expanded filing live in the address bar.
68 facts held from the Form 6-K HIVE filed 2025-11-17.
Facts are the XBRL values in the site's concept set, as tagged by the filer; the full instance holds more. Primary document, filing index.
| Concept | Value | Period | Fiscal |
|---|---|---|---|
| Assetsus-gaap:Assets | $531.6M | 2025-03-31 | Q2 FY 2025 |
| Assetsus-gaap:Assets | $693M | 2025-09-30 | Q2 FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalentsus-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $9.7M | 2024-03-31 | Q2 FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalentsus-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $7.2M | 2024-09-30 | Q2 FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalentsus-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $23.4M | 2025-03-31 | Q2 FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalentsus-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | $22.6M | 2025-09-30 | Q2 FY 2025 |
| CryptoAssetFairValueus-gaap:CryptoAssetFairValue | $181.1M | 2025-03-31 | Q2 FY 2025 |
| CryptoAssetFairValueus-gaap:CryptoAssetFairValue | $24.4M | 2025-09-30 | Q2 FY 2025 |
| Depreciationus-gaap:Depreciation | $28.5M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Depreciationus-gaap:Depreciation | $60.3M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Earnings Per Share, Basicus-gaap:EarningsPerShareBasic | -0.16 | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Earnings Per Share, Basicus-gaap:EarningsPerShareBasic | 0.00 | 2024-07-01 to 2024-09-30 | Q2 FY 2025 |
| Earnings Per Share, Basicus-gaap:EarningsPerShareBasic | 0.09 | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Earnings Per Share, Basicus-gaap:EarningsPerShareBasic | -0.07 | 2025-07-01 to 2025-09-30 | Q2 FY 2025 |
| Earnings Per Share, Dilutedus-gaap:EarningsPerShareDiluted | -0.16 | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Earnings Per Share, Dilutedus-gaap:EarningsPerShareDiluted | 0.00 | 2024-07-01 to 2024-09-30 | Q2 FY 2025 |
| Earnings Per Share, Dilutedus-gaap:EarningsPerShareDiluted | 0.09 | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Earnings Per Share, Dilutedus-gaap:EarningsPerShareDiluted | -0.07 | 2025-07-01 to 2025-09-30 | Q2 FY 2025 |
| Income Tax Expense (Benefit)us-gaap:IncomeTaxExpenseBenefit | $1.3M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Income Tax Expense (Benefit)us-gaap:IncomeTaxExpenseBenefit | $318K | 2024-07-01 to 2024-09-30 | Q2 FY 2025 |
| Income Tax Expense (Benefit)us-gaap:IncomeTaxExpenseBenefit | $1.7M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Income Tax Expense (Benefit)us-gaap:IncomeTaxExpenseBenefit | $1M | 2025-07-01 to 2025-09-30 | Q2 FY 2025 |
| Interest Expenseus-gaap:InterestExpense | $223K | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Interest Expenseus-gaap:InterestExpense | $151K | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Liabilitiesus-gaap:Liabilities | $82.5M | 2025-03-31 | Q2 FY 2025 |
| Liabilitiesus-gaap:Liabilities | $68.4M | 2025-09-30 | Q2 FY 2025 |
| Net Cash Provided by (Used in) Financing Activitiesus-gaap:NetCashProvidedByUsedInFinancingActivities | $32M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Net Cash Provided by (Used in) Financing Activitiesus-gaap:NetCashProvidedByUsedInFinancingActivities | $107.3M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Net Cash Provided by (Used in) Investing Activitiesus-gaap:NetCashProvidedByUsedInInvestingActivities | -$28M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Net Cash Provided by (Used in) Investing Activitiesus-gaap:NetCashProvidedByUsedInInvestingActivities | -$108.1M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Net Cash Provided by (Used in) Operating Activitiesus-gaap:NetCashProvidedByUsedInOperatingActivities | -$6.5M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Net Cash Provided by (Used in) Operating Activitiesus-gaap:NetCashProvidedByUsedInOperatingActivities | -$384K | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Net Income (Loss) Attributable to Parentus-gaap:NetIncomeLoss | -$18.3M | 2024-04-01 to 2024-06-30 | Q2 FY 2025 |
| Net Income (Loss) Attributable to Parentus-gaap:NetIncomeLoss | -$18.2M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Net Income (Loss) Attributable to Parentus-gaap:NetIncomeLoss | $80K | 2024-07-01 to 2024-09-30 | Q2 FY 2025 |
| Net Income (Loss) Attributable to Parentus-gaap:NetIncomeLoss | $35M | 2025-04-01 to 2025-06-30 | Q2 FY 2025 |
| Net Income (Loss) Attributable to Parentus-gaap:NetIncomeLoss | $19.2M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Net Income (Loss) Attributable to Parentus-gaap:NetIncomeLoss | -$15.8M | 2025-07-01 to 2025-09-30 | Q2 FY 2025 |
| Operating Expensesus-gaap:OperatingExpenses | $8.9M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Operating Expensesus-gaap:OperatingExpenses | $3.8M | 2024-07-01 to 2024-09-30 | Q2 FY 2025 |
| Operating Expensesus-gaap:OperatingExpenses | $21.3M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Operating Expensesus-gaap:OperatingExpenses | $12.7M | 2025-07-01 to 2025-09-30 | Q2 FY 2025 |
| Proceeds from Issuance of Common Stockus-gaap:ProceedsFromIssuanceOfCommonStock | $35.9M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Proceeds from Issuance of Common Stockus-gaap:ProceedsFromIssuanceOfCommonStock | $139.2M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Property, Plant and Equipment, Netus-gaap:PropertyPlantAndEquipmentNet | $202.8M | 2025-03-31 | Q2 FY 2025 |
| Property, Plant and Equipment, Netus-gaap:PropertyPlantAndEquipmentNet | $464.3M | 2025-09-30 | Q2 FY 2025 |
| Revenuesus-gaap:Revenues | $54.9M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Revenuesus-gaap:Revenues | $22.6M | 2024-07-01 to 2024-09-30 | Q2 FY 2025 |
| Revenuesus-gaap:Revenues | $132.9M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Revenuesus-gaap:Revenues | $87.3M | 2025-07-01 to 2025-09-30 | Q2 FY 2025 |
| Selling, General and Administrative Expenseus-gaap:SellingGeneralAndAdministrativeExpense | $6.8M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Selling, General and Administrative Expenseus-gaap:SellingGeneralAndAdministrativeExpense | $3.4M | 2024-07-01 to 2024-09-30 | Q2 FY 2025 |
| Selling, General and Administrative Expenseus-gaap:SellingGeneralAndAdministrativeExpense | $13.6M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Selling, General and Administrative Expenseus-gaap:SellingGeneralAndAdministrativeExpense | $7.8M | 2025-07-01 to 2025-09-30 | Q2 FY 2025 |
| Stockholders' Equity Attributable to Parentus-gaap:StockholdersEquity | $259.4M | 2024-03-31 | Q2 FY 2025 |
| Stockholders' Equity Attributable to Parentus-gaap:StockholdersEquity | $268.6M | 2024-06-30 | Q2 FY 2025 |
| Stockholders' Equity Attributable to Parentus-gaap:StockholdersEquity | $275.5M | 2024-09-30 | Q2 FY 2025 |
| Stockholders' Equity Attributable to Parentus-gaap:StockholdersEquity | $449.1M | 2025-03-31 | Q2 FY 2025 |
| Stockholders' Equity Attributable to Parentus-gaap:StockholdersEquity | $560.5M | 2025-06-30 | Q2 FY 2025 |
| Stockholders' Equity Attributable to Parentus-gaap:StockholdersEquity | $624.6M | 2025-09-30 | Q2 FY 2025 |
| Weighted Average Number of Shares Outstanding, Dilutedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | 114.7M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Weighted Average Number of Shares Outstanding, Dilutedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | 118.6M | 2024-07-01 to 2024-09-30 | Q2 FY 2025 |
| Weighted Average Number of Shares Outstanding, Dilutedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | 218.3M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Weighted Average Number of Shares Outstanding, Dilutedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding | 228.1M | 2025-07-01 to 2025-09-30 | Q2 FY 2025 |
| Weighted Average Number of Shares Outstanding, Basicus-gaap:WeightedAverageNumberOfSharesOutstandingBasic | 114.7M | 2024-04-01 to 2024-09-30 | Q2 FY 2025 |
| Weighted Average Number of Shares Outstanding, Basicus-gaap:WeightedAverageNumberOfSharesOutstandingBasic | 118.6M | 2024-07-01 to 2024-09-30 | Q2 FY 2025 |
| Weighted Average Number of Shares Outstanding, Basicus-gaap:WeightedAverageNumberOfSharesOutstandingBasic | 205.2M | 2025-04-01 to 2025-09-30 | Q2 FY 2025 |
| Weighted Average Number of Shares Outstanding, Basicus-gaap:WeightedAverageNumberOfSharesOutstandingBasic | 228.1M | 2025-07-01 to 2025-09-30 | Q2 FY 2025 |
12,311 filings match; showing 1401 to 1500.
| Filed | Company | Form | Document | Period | Facts held |
|---|---|---|---|---|---|
| 2025-12-05 | CLSK | Form 4 | Form 4, 2025-12-05 | 2025-12-03 | 0 |
| 2025-12-05 | CLSK | Form 144 | Form 144, 2025-12-05 | 0 | |
| 2025-12-05 | ANY | DEFA14A | DEFA14A | 0 | |
| 2025-12-05 | ANY | DEF 14A | DEF 14A | 2026-01-15 | 0 |
| 2025-12-05 | CIFR | Form 144 | Form 144, 2025-12-05 | 0 | |
| 2025-12-04 | CLSK | Form 144 | Form 144, 2025-12-04 | 0 | |
| 2025-12-04 | IREN | Form 424B5 | 424B5 | 0 | |
| 2025-12-04 | DGXX | Form 144 | Form 144, 2025-12-04 | 0 | |
| 2025-12-03 | RIOT | Form 4 | Form 4, 2025-12-03 | 2025-12-01 | 0 |
| 2025-12-03 | ARBK | Form 6-K | RESULTS OF MEETINGS | 2025-12-03 | 0 |
| 2025-12-03 | CLSK | SCHEDULE 13G/A | SCHEDULE 13G/A, 2025-12-03 | 0 | |
| 2025-12-03 | DGXX | Form 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-03 | 0 |
| 2025-12-03 | IREN | Form 8-K | 8-KItems 8.01, 9.01 | 2025-12-03 | 0 |
| 2025-12-03 | IREN | FWP | FWP | 0 | |
| 2025-12-02 | MSTR | Form 3 | Form 3, 2025-12-02 | 2025-12-01 | 0 |
| 2025-12-01 | CORZ | SCHEDULE 13D/A | SCHEDULE 13D/A, 2025-12-01 | 0 | |
| 2025-12-01 | IREN | Form 8-K | 8-KItems 8.01, 9.01 | 2025-12-01 | 0 |
| 2025-12-01 | IREN | Form 424B5 | 424B5 | 0 | |
| 2025-12-01 | VIP | Form 8-K | 8-KItems 1.01, 9.01 | 2025-11-26 | 0 |
| 2025-12-01 | MSTR | Form 8-K | 8-KItems 5.02, 7.01, 8.01, 9.01 | 2025-11-30 | 0 |
| 2025-11-28 | CIFR | Form 4 | FORM 4 | 2025-11-26 | 0 |
| 2025-11-28 | CIFR | Form 4 | FORM 4 | 2025-11-26 | 0 |
| 2025-11-28 | IREN | Form 8-K | 8-KItems 4.01, 9.01 | 2025-11-26 | 0 |
| 2025-11-28 | ARBK | Form 6-K | SUPPLEMENTARY EXPLANATORY STATEMENT | 2025-11-28 | 0 |
| 2025-11-28 | ARBK | F-6 | F-6 | 0 | |
| 2025-11-26 | VIP | Form 8-K | 8-KItems 8.01 | 2025-11-23 | 0 |
| 2025-11-26 | HIVE | Form 6-K | FORM 6-K | 2025-11-25 | 0 |
| 2025-11-25 | BTDR | SCHEDULE 13D/A | SCHEDULE 13D/A, 2025-11-25 | 0 | |
| 2025-11-25 | HIVE | Form 424B5 | FORM 424B5 | 0 | |
| 2025-11-25 | CLSK | Form 10-K | 10-K | 2025-09-30 | 80 |
| 2025-11-25 | MSTR | Form 4 | Form 4, 2025-11-25 | 2025-11-21 | 0 |
| 2025-11-25 | CLSK | Form 8-K | 8-KItems 2.02, 9.01 | 2025-11-25 | 0 |
| 2025-11-25 | WULF | Form 8-K | 8-KItems 3.03, 8.01 | 2025-11-25 | 0 |
| 2025-11-25 | BGDE | Form 8-K | CURRENT REPORTItems 2.02, 9.01 | 2025-11-25 | 0 |
| 2025-11-24 | CIFR | Form 8-K | FORM 8-KItems 1.01, 2.03, 9.01 | 2025-11-24 | 0 |
| 2025-11-24 | BTBT | Form 4 | Form 4, 2025-11-24 | 2025-11-20 | 0 |
| 2025-11-24 | IREN | Form 8-K | 8-KItems 3.03, 5.02, 5.07, 9.01 | 2025-11-19 | 0 |
| 2025-11-24 | ARBK | Form 6-K | ADS RATIO CHANGE EFFECTIVE DATE | 2025-11-24 | 0 |
| 2025-11-21 | WULF | Form 4 | FORM 4 | 2025-11-20 | 0 |
| 2025-11-21 | ANY | S-3 | FORM S-3 | 0 | |
| 2025-11-21 | BGDE | Form 8-K | CURRENT REPORTItems 3.03, 5.03, 8.01, 9.01 | 2025-11-19 | 0 |
| 2025-11-21 | ARBK | Form 6-K | Form 6-K, 2025-11-21 | 2025-11-21 | 0 |
| 2025-11-20 | HIVE | F-3ASR | FORM F-3ASR | 0 | |
| 2025-11-20 | MSTR | Form 4 | Form 4, 2025-11-20 | 2025-11-18 | 0 |
| 2025-11-20 | RIOT | SCHEDULE 13G | SCHEDULE 13G, 2025-11-20 | 0 | |
| 2025-11-20 | CIFR | Form 8-K | FORM 8-KItems 1.01, 7.01, 8.01, 9.01 | 2025-11-20 | 0 |
| 2025-11-20 | DGXX | Form 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-20 | 0 |
| 2025-11-19 | MARA | Form 4 | Form 4, 2025-11-19 | 2025-11-17 | 0 |
| 2025-11-19 | MARA | Form 4 | Form 4, 2025-11-19 | 2025-11-17 | 0 |
| 2025-11-19 | MSTR | Form 4 | Form 4, 2025-11-19 | 2025-11-17 | 0 |
| 2025-11-19 | CIFR | Form 4 | FORM 4 | 2025-11-17 | 0 |
| 2025-11-19 | BTDR | Form 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-19 | 0 |
| 2025-11-19 | MSTR | Form 144 | Form 144, 2025-11-19 | 0 | |
| 2025-11-19 | BGDE | Form 8-K | CURRENT REPORTItems 8.01, 9.01 | 2025-11-19 | 0 |
| 2025-11-18 | MSTR | Form 4 | Form 4, 2025-11-18 | 2025-11-14 | 0 |
| 2025-11-18 | CIFR | SCHEDULE 13D/A | SCHEDULE 13D/A, 2025-11-18 | 0 | |
| 2025-11-18 | CIFR | Form 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-14 | 0 |
| 2025-11-18 | DGXX | Form 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-18 | 0 |
| 2025-11-18 | DGXX | SUPPL | PROSPECTUS SUPPLEMENT | 0 | |
| 2025-11-18 | ANY | PRE 14A | PRE 14A | 2026-01-15 | 0 |
| 2025-11-18 | MSTR | Form 144 | Form 144, 2025-11-18 | 0 | |
| 2025-11-18 | HIVE | Form 6-K | FORM 6-K | 2025-11-17 | 0 |
| 2025-11-17 | CORZ | SCHEDULE 13D/A | SCHEDULE 13D/A, 2025-11-17 | 0 | |
| 2025-11-17 | VIP | Form 4 | FORM 4 | 2025-11-09 | 0 |
| 2025-11-17 | VIP | Form 4 | FORM 4 | 2025-11-09 | 0 |
| 2025-11-17 | VIP | Form 4 | FORM 4 | 2025-11-09 | 0 |
| 2025-11-17 | MSTR | Form 144 | Form 144, 2025-11-17 | 0 | |
| 2025-11-17 | MARA | Form 144 | Form 144, 2025-11-17 | 0 | |
| 2025-11-17 | CIFR | Form 144 | Form 144, 2025-11-17 | 0 | |
| 2025-11-17 | MARA | Form 144 | Form 144, 2025-11-17 | 0 | |
| 2025-11-17 | HIVE | Form 6-K | FORM 6-K | 2025-09-30 | 68 |
| 2025-11-17 | MSTR | Form 8-K | 8-KItems 7.01, 8.01 | 2025-11-17 | 0 |
| 2025-11-17 | HUT | Form 8-K | 8-KItems 7.01, 9.01 | 2025-11-17 | 0 |
| 2025-11-17 | KEEL | Form 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-14 | 0 |
| 2025-11-14 | CIFR | Form 4 | FORM 4 | 2025-11-12 | 0 |
| 2025-11-14 | CIFR | Form 4 | FORM 4 | 2025-11-12 | 0 |
| 2025-11-14 | ANY | SCHEDULE 13G/A | SCHEDULE 13G/A, 2025-11-14 | 0 | |
| 2025-11-14 | ARBK | SCHEDULE 13G/A | SCHEDULE 13G/A, 2025-11-14 | 0 | |
| 2025-11-14 | BTDR | Form 424B5 | PROSPECTUS SUPPLEMENT | 0 | |
| 2025-11-14 | VIP | Form 8-K | 8-KItems 5.02 | 2025-11-14 | 0 |
| 2025-11-14 | CORZ | SCHEDULE 13G | SCHEDULE 13G, 2025-11-14 | 0 | |
| 2025-11-14 | BGDE | Form 10-Q | QUARTERLY REPORT | 2025-09-30 | 89 |
| 2025-11-14 | BGDE | Form 8-K | CURRENT REPORTItems 2.02, 9.01 | 2025-11-14 | 0 |
| 2025-11-14 | MSTR | Form 4 | Form 4, 2025-11-14 | 2025-11-12 | 0 |
| 2025-11-14 | HIVE | SCHEDULE 13G/A | SCHEDULE 13G/A, 2025-11-14 | 0 | |
| 2025-11-14 | MSTR | Form 144 | Form 144, 2025-11-14 | 0 | |
| 2025-11-14 | BTBT | Form 10-Q | QUARTERLY REPORT | 2025-09-30 | 105 |
| 2025-11-14 | DGXX | Form 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-14 | 0 |
| 2025-11-14 | BTBT | Form 8-K | CURRENT REPORTItems 2.02, 9.01 | 2025-11-14 | 0 |
| 2025-11-13 | MSTR | SCHEDULE 13G | SCHEDULE 13G, 2025-11-13 | 0 | |
| 2025-11-13 | IREN | SCHEDULE 13G/A | SCHEDULE 13G/A, 2025-11-13 | 0 | |
| 2025-11-13 | MSTR | SCHEDULE 13G/A | SCHEDULE 13G/A, 2025-11-13 | 0 | |
| 2025-11-13 | MARA | SCHEDULE 13G/A | SCHEDULE 13G/A, 2025-11-13 | 0 | |
| 2025-11-13 | IREN | SCHEDULE 13G | SCHEDULE 13G, 2025-11-13 | 0 | |
| 2025-11-13 | HUT | SCHEDULE 13G | SCHEDULE 13G, 2025-11-13 | 0 | |
| 2025-11-13 | CORZ | SCHEDULE 13G/A | SCHEDULE 13G/A, 2025-11-13 | 0 | |
| 2025-11-13 | CLSK | SCHEDULE 13G | SCHEDULE 13G, 2025-11-13 | 0 | |
| 2025-11-13 | CIFR | SCHEDULE 13G | SCHEDULE 13G, 2025-11-13 | 0 | |
| 2025-11-13 | CIFR | Form 8-K | FORM 8-KItems 1.01, 2.03, 9.01 | 2025-11-13 | 0 |
| 2025-11-13 | CORZ | Form 4 | Form 4, 2025-11-13 | 2025-11-12 | 0 |